Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETAC®

Pediatric Allergy and Immunology

Volumn 9, Issue 3, 1998, Pages 116-124

  Wahn, Ulrich ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Asthma; Atopy; Cetirizine; Child; Dermatitis; Grass pollen; House dust mite; IgE; Infant; Prevention

Indexed keywords

CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E;

ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE BLIND PROCEDURE; FEMALE; GRASS POLLEN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK;

EID: 0005065215     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.1998.tb00356.x     Document Type: Article

References (32)

1. ASHER MI, KEIL U, ANDERSON HR, et al. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, atopic eczema: ISAAC. Lancet 1998: 351: 1225-32.
2. WAHN U, BERGMANN R, KULIG M, FORSTER J, BAUER CP. The natural course of sensitisation and atopic disease in infancy and childhood. Pediatr Allergy Immunol 1997: 8 Suppl 10: 16-20.
3. ZEIGER RS, HELLER S, MELLON MH, HALSEY JF, HAMBURGER RN, SAMPSON HA. Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomised study of food allergen avoidance. Pediatr Allergy Immunol 1992: 3: 110-27.
4. HIDE DW, MATTHEWS S, TARIQ S, ARSHAD SH. Allergen avoidance in infancy and allergy at 4 years of age. Allergy 1996: 51(2): 89-93.
5. SAARINEN UM, KAJOSAARI M. Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years. Lancet 1995: 346: 1065-9
6. BERGMANN RL, EDENHARTER G, BERGMANN KE, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998: 28: 965-70.
7. IIKURA Y, NASPITZ CK, MIKAWA H, et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992: 68: 233-6.
8. BUSTOS GJ, BUSTOS D, BUSTOS GJ, ROMERO O. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin Exp Allergy 1995: 25(6): 568-73.
9. STANCIU LA, DJUKANOVIC R. The role of ICAM-1 on T-cells in the pathogenesis of asthma. Europ Respir J 1998: 11: 949-57.
10. SNYDER SH, SNOWMAN AM. Receptor effects of cetirizine. Ann Allergy 1987: 59: 4-8.
11. SIMONS FE. New H1-receptor antagonists: clinical pharmacology. Clin Exp Allergy 1990: 20 Suppl 2: 19-24.
12. GHYS L, RIHOUX JP. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole. J Int Med Res 1989: 17(1): 24-7.
13. CAMPOLI-RICHARDS DM, BUCKLEY MM, FITON A. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma and chronic urticaria. Drugs 1990: 40(5): 762-81.
14. FASCE L, CIPRANDI G, PRONZATO C, et al. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with miteallergic asthma. Int Arch Allergy Immunol 1996: 109(3): 272-6.
15. CIPRANDI G, BUSCAGLIA S, PESCE G, et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995: 95(2): 612-21.
16. 1 receptor blockade on the early and late reponse to cutaneous allergen challenge. J Pharmacol Exp Ther 1992: 262: 964-70.
17. REDIER H, CHANEZ P, DE Vos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992: 90(2): 215-24.
18. National Institute of Health. Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program. Expert Panel Report II. National Institute of Health publication 97-4051. Bethesda, MD: National Instiute of Health; 1997.
19. National Institute of Health. International Report. International concensus report on diagnosis and treatment of asthma. National Heart, Lung and Blood Institute. National Institute of Health publication 92-3091. Bethesda. MD: National Institute of Health; 1992.
20. Consensus Report of the European Task Force on Atopic Dermatitis. Severity Scoring of Atopic Dermatitis: the SCORAD Index. Dermatology 1993: 186: 23-31.
21. ORANJE AP, STALDER JF, TAÏEB A, TASSET C, DE Longueville M. Scoring of atopic dermatitis by SCORAD using training atlas by investigators from different disciplines. Pediatr Allergy Immunol 1997: 8: 28-34.
22. Asthma: a follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992: 67: 240-8.
23. DIEPGEN TL, SAUERBREI W, FARTASCH M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996: 49(9): 1031-8.
24. SAMPSON HA. Atopic dermatitis. Ann Allergy 1992: 69(6): 469-79.
25. CRONER S, KJELLMAN M. Development of atopic disease in relation to family history and cord blood IgE levels. Pediatr Allergy Immunol 1990: 1: 14-20.
26. ETAC® Study Group. Determinant of total and specific IgE in infants with atopic dermatitis. Pediatr Allergy Immunol 1997: 8: 177-84.
27. MARKS GB, TOVEY ER, GREEN W, SHEARER M, SALOME CM, WOOLCOCK AJ. The effect of changes in house dust mite allergen exposure on the severity of asthma. Clin Exp Allergy 1995: 25(2): 114-8.
28. QUIRCE S, DIMICH-WARD H, CHAN H, et al. Major cat allergen (Fel d I) levels in the homes of patients with asthma and their relationship to sensitization to cat dander. Ann Allergy Asthma Immunol 1995: 75(4): 325-30.
29. BURR ML, MERRETT TG, DUNSTAN FD, MAGUIRE MJ. The development of allergy in high-risk children. Clin Exp Allergy 1997: 27(11): 1247-53.
30. FERGUSON AC, WHITELAW M, BROWN H. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992: 90(4 Pt 1): 609-13.
31. SPORIK R, HOLGATE S, PLATTS-MILLS TA, COGSWELL JJ. Exposure to house dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Eng J Med 1990: 323(8): 502-7.
32. RIDOUT SM, TARIQ SM. Cetirizine overdose in a young child [letter]. J Allergy Clin Immunol 1997: 99(6): 860-1.